AMSTAMSTTechnology · Software - Application

AMST Stock Forecast: Amesite, Inc. Price Predictions for 2026-2027

Last close, 12 Oct 2026
$0.83
−5.24% on the day

Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 31 of 100 as at 12 Oct 2026 — in the lower half.

Market cap
$5.7M
Ticker Nerd rank
31 / 100
Median analyst target
—
Analysts covering
0
Revenue$83K+171.5% y/y
Operating income−$684K
Net income−$678K
Free cash flow−$525K
Quarterly, 8 quarters to 31 Mar 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−11.9%
1M
−19.8%
YTD
−56.1%
1Y
−75.7%
From 52W high
−77.7%
From 52W low
+5.6%
$0.79
$3.73
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

AMST stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Amesite, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 12 Oct 2026
31 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Size
95
Growth
83
Accruals
83
Momentum
33
Issuance
31
Volatility
26
Revisions
25
Quality
15
Value
6

Size (95): Smaller than most of the companies we track.

Value (6): The shares cost a lot relative to the profits and assets behind them.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

AMST stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on AMST, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$0.50$1.00$1.50$2.00$2.50$3.00$3.50$4.00Jan 26Apr 26Jul 26Oct 26AMST

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. AMST appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

AMST vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 12 Oct 2026, Amesite, Inc. returned −75.7% against +20.4% for the S&P 500, dividends included.

AMST vs S&P 500, last 12 monthsTotal return, rebased to 100
20406080100120Jan 26Apr 26Jul 26Oct 26AMSTS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

AMST analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Fundamentals

Amesite, Inc. (AMST) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
−0.8×

Cheaper than 82% of US stocks

Price / sales
15.7×

Cheaper than 10% of US stocks

Price / book
2.2×

Cheaper than 41% of US stocks

EV / EBITDA
−1.2×

Cheaper than 69% of US stocks

Growth & margins
Revenue growth (YoY)
41.9%

Higher than 83% of US stocks

Earnings growth (YoY)
171.5%

Higher than 89% of US stocks

Gross margin
—
Operating margin
−1329.5%

Higher than 5% of US stocks

Net margin
0.0%

Higher than 30% of US stocks

Returns & dividend
Return on equity
−114.8%

Higher than 12% of US stocks

Return on assets
−64.1%

Higher than 6% of US stocks

Dividend yield
0.0%

Higher than 1% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Amesite, Inc. (AMST) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Amesite, Inc. has a market value of $5.7M and an enterprise value of $3.7M.

  • Revenue in the twelve months to 31 Mar 2026: $341K. The latest quarter grew 41.9% year on year.

  • Net income over the same four quarters: −$3.0M, a −871.9% net margin.

  • Free cash flow in the twelve months to 31 Mar 2026: −$2.2M, after $293K of capital spending.

  • Shares outstanding: 4.7M.

  • Trailing P/E: −0.8×.

  • Forward dividend yield: 0.00%, paying out 0% of earnings.

  • Amesite, Inc. employs 5 people — $68K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 31 Mar 2026 · market figures as at 13 Oct 2026

Data provided by Twelve Data

Peers

AMST vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelSoftware - Application
CompanyMarket capTKN rank
AMSTAmesite, Inc.$5.7M
31
ORKTOrangekloud Technology, Inc.$5.5M
12
JTAIJet.AI, Inc.$5.2M
27
AUUDAuddia, Inc.$5.9M
15
NVNINvni Group Ltd.$6.2M
—
CXAICXApp, Inc.$4.6M
35
VSVersus Systems, Inc.$6.5M
19

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Amesite, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest AMST news & analysis

Amesite Announces New Sales Win Under NurseMagic® Minimum Enterprise Pricing Model

GlobeNewsWire · 24 Sept 2026positive

Amesite, Inc. announced a new sales win under its NurseMagic® minimum enterprise pricing model. The company estimates that agreements at the new pricing level can generate approximately 85% gross margin, supporting scalable growth across post-acute care organizations.

Why it matters — AMST watchers would care because the new sales win at the higher pricing model, with an estimated 85% gross margin, signals potential for more profitable and scalable growth in the post-acute care market.

FAQ

Frequently asked questions about AMST stock

How does Ticker Nerd's model rank AMST?

As at 12 Oct 2026, Amesite, Inc. ranks 31 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (95 of 100).

What is the AMST stock forecast for 2030?

No analyst covering Amesite, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for AMST are extrapolating price history, which says nothing about the business.

How has AMST stock performed over the past year?

Amesite, Inc. returned -75.7% over the 12 months to 12 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Amesite, Inc. do?

Amesite Inc. is an AI-driven technology company focused on software products for healthcare and digital learning.

What is the latest news on AMST?

The most recent item we track (GlobeNewsWire, 24 Sept 2026): "Amesite Announces New Sales Win Under NurseMagic® Minimum Enterprise Pricing Model". Amesite, Inc. announced a new sales win under its NurseMagic® minimum enterprise pricing model. The company estimates that agreements at the new pricing level can generate approximately 85% gross margin, supporting scalable growth across post-acute care organizations.

Company

About Amesite, Inc.

Amesite Inc. is an AI-driven technology company focused on software products for healthcare and digital learning. Its flagship NurseMagic app helps nurses and caregivers create documentation, support patient communication, and manage daily workflow tasks more efficiently, while its broader AI platform also serves businesses and educational organizations with customizable online learning and training tools. The company provides both B2B and B2C solutions, with products designed to fit existing workflows and support regulated environments such as healthcare. Amesite Inc. serves customers across healthcare, enterprise, higher education, and K-12 markets, positioning itself as a provider of practical AI applications for professional productivity and training.

CEO Dr. Ann Marie Sastry Ph.D. · 5 employees · United States · https://www.amesite.com